Live Breaking News & Updates on Accordion Pill

Stay updated with breaking news from Accordion pill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IPX-203 shows good results for motor fluctuations in Parkinson's disease

IPX-203 shows good results for motor fluctuations in Parkinson's disease
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Amneal Rytary , Amneal Pharmaceuticals , Movement Disorder Society , Drug Administration , Good On , Patient Global Impression , Unified Parkinson , Disease Rating Scale , Accordion Pill ,

Intec Pharma Ltd. - Consensus Indicates Potential 120.0% Upside

Intec Pharma Ltd. - Consensus Indicates Potential 120.0% Upside
directorstalkinterviews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from directorstalkinterviews.com Daily Mail and Mail on Sunday newspapers.

Israel General , Carbidopa Levodopa , Intec Pharma Ltd , Intec Pharmaceuticals , Gw Research , Wintec Pharma , Pharma Ltd , Accordion Pill , Its Accordion Pill , Accordion Pill Zaleplon , Nonsteroidal Anti Inflammatory Drug ,

Stockholder Alleges Intec Pharma's Registration Statement for Proposed Merger Misled Investors


Health
your username
6 days ago
A stockholder is suing Intec Pharma Ltd., Intec’s board of directors, and related entities over alleged violations of the Securities Exchange Act, per a Friday complaint filed in the District of Delaware regarding a proposed merger.
Plaintiff Craig Davidson is an owner of common stock of Intec, a biopharmaceutical company developing drug products based on its Accordion Pill platform that seeks to “improve the efficacy and safety” of drug products. On March 15, Intec’s board of directors executed a merger agreement with Intec Parent, Inc., Dillion Merger Subsidiary Inc., Domestication Merger Sub Ltd., and Decoy Biosystems Inc. The companies said in a news release that they are aiming for the merger to be executed in the third quarter of 2021, the complaint detailed. A registration statement with the Securities and Exchange Commission (SEC) followed on April 20. ....

United States , Craig Davidson , Exchange Commission , Intec Parent Inc , Dillion Merger Subsidiary Inc , Intec Pharma Ltd , Domestication Merger Sub Ltd , Securities Exchange , Decoy Biosystems Inc , Securities Exchange Act , Accordion Pill , Intec Parent , Decoy Biosystems , Registration Statement , ஒன்றுபட்டது மாநிலங்களில் , கிரேக் டேவிட்சன் , பரிமாற்றம் தரகு , ஈந்தெக் பார்மா லிமிடெட் , பத்திரங்கள் பரிமாற்றம் , சிதைவு உயிர் அமைப்புகள் இன்க் , பத்திரங்கள் பரிமாற்றம் நாடகம் , இசைக்கருவி வகை மாத்திரை , சிதைவு உயிர் அமைப்புகள் , பதிவு அறிக்கை ,

Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K
Intec Pharma LtdMarch 17, 2021 GMT
JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission. A copy of the annual report is available on Intec’s website, www.intecpharma.com, by selecting “Investors” and then “Financials” and “SEC Filings”.
You may request a copy of the Company’s Form 10-K, at no cost to you, by writing to the Chief Financial Officer of the Company at 12 Hartom Street, Har Hotzvim, Jerusalem 9777512, Israel or by calling the Company at +972 (2) 586 4657. ....

Israel General , Wintec Pharma , Har Hotzvim , Exchange Commission , Company Form , Intec Pharma Ltd , Company Accordion Pill , Chief Financial Officer , Accordion Pill , Investor Relations , Proposed Merger , Decoy Biosystems , Registration Statement , Decoy Biosystem , Annual Report , Private Securities Litigation Reform , Pharma Investor Contact , Corporate News , Pharmaceutical Manufacturing , Government Regulations , Ownership Changes , Middle East , Sec Filings , Product Approvals , New Products And Services , Government And Politics ,